Locoregional radiotherapy improves survival outcomes in de novo metastatic nasopharyngeal carcinoma treated with chemoimmunotherapy

BACKGROUND: We aimed to investigate the efficacy of locoregional radiotherapy (LRRT) in patients with de novo metastatic nasopharyngeal carcinoma (dmNPC) receiving chemotherapy combined with anti-programmed cell death receptor-1 monoclonal antibodies (anti-PD-1 mAbs) as first-line treatment and iden...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Y.-J., Lu, T.-Z., Zhang, H., Fang, M., Chen, B.-J., Guo, Q.-J., Lin, S.-J., Feng, P., Wang, Y., Jiang, T.-C., Gong, X.-C., Pan, J.-J., Li, J.-G., Xia, Y.-F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594020/
https://www.ncbi.nlm.nih.gov/pubmed/37660406
http://dx.doi.org/10.1016/j.esmoop.2023.101629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594020/
https://www.ncbi.nlm.nih.gov/pubmed/37660406
http://dx.doi.org/10.1016/j.esmoop.2023.101629

Ejemplares similares